Treatment of Anxiety and Depression in Distressed Carers for Persons with Dementia-related Conditions
- Conditions
- DepressionAnxietyMental Health - DepressionMental Health - Anxiety
- Registration Number
- ACTRN12611000575932
- Lead Sponsor
- Macquarie University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
1) reporting at least moderate (sub-clinical or clinical) levels of anxiety and/or depressive symptoms; 2) CG for a person diagnosed with a dementia-related condition; 3) care recipient has a minimum of at least 12-month prognosis; 4) aged 18 to 80 years; 5) able to speak, read and write basic English; and 6) medically fit to respond to the assessment and intervention procedures.
(1) Presence of severe cognitive and language deficits for CGs (defined as score < 1.96 SD below mean) that will be assessed via a brief screening neuropsychological assessment battery (see measures); (2) current or prior history of significant alcohol/ drug abuse or psychosis; (3) current suicidal ideation; and (4) currently undergoing psychiatric treatment for mental illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression: Beck Depression Inventory (2nd Ed) [BDI-II], sample mean scores to reduce to non-clinical levels (< 14)[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Anxiety: State Trait Anxiety Scale (STAI), sample means scores to reduce to non-clinical levels [T scores < 60][Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Acceptance: Acceptance and Action Questionnaire, sample mean scores will improve on acceptance subscale and reduce on experiential subscale.[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).]
- Secondary Outcome Measures
Name Time Method Coping strategies: BCOPE, sample means scores expected to improve on adapative coping and reduce on maladaptive coping.[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Quality of Life [QOL], SF-36: sample mean scores expected to increase reflecting improvment in QOL[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).];Caregiver Functionality: Positive Aspects of Caregiving Scale, sample means scores expected to improve.[Baseline, end of therapy (10 weeks following commencement of intervention), 1-month and 3 -months follow up (i.e., 14 and 26 weeks following commencement of intervention).]